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Ultraviolet (UV) irradiation of the skin causes both
inflammation and alterations in the skin immune system.
There is increasing experimental evidence that UV-
induced skin inflammation is influenced by the sensory
nervous system and the neuroendocrine system in the
skin. The resulting complex network of cytokines,
chemokines, neuropeptides, neuropeptide-degrading
enzymes, neurohormones, and other inflammatory medi-
ators mediate photodermatitis and cutaneous inflamma-
tion. Neuropeptides such as substance P (SP) and
calcitonin gene-related peptide (CGRP) are released from
sensory nerves innervating the skin upon UV exposure.
In addition, a variety of cells in the skin produce increased
neuroendocrine hormones such as proopiomelanocortin
(POMC) peptides and their receptors as well as neurotro-
phins after UV exposure. Neuropeptides and neurohor-
mones are capable of directly or indirectly mediating
Exposure of the skin to UV irradiation causes erythema,edema, heat, and pain and profoundly influences thebiologic functions of a variety of epidermal and dermalcells, including keratinocytes, melanocytes, Langerhanscells, mast cells, dermal fibroblasts, and endothelial cells.
Biological, biochemical, and immunohistochemical studies reveal that
these cells as well as skin-infiltrating inflammatory cells release pro-
inflammatory and immunosuppressive cytokines, chemokines, growth
factors, and neurohormones after UV irradiation, which creates a
complex network of interacting inflammatory mediators. UV light has
also been implicated in cutaneous carcinogenesis and in local as well
as systemic immunosuppression, including impaired contact hyper-
sensitivity (CHS), delayed-type hypersensitivity (DTH), and the
induction of immunologic tolerance. These immunosuppressive
responses have been attributed to cellular DNA damage, impaired
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UV-induced cutaneous neurogenic inflammation by the
induction of vasodilatation, plasma extravasation, and
augmentation of UV-induced cytokine, chemokine, or
cellular adhesion molecule expression required for activa-
tion and trafficking of inflammatory cells into the
inflamed tissue. Neuropeptides and neurotrophins may
also play a role in the repair of cutaneous UV injury. In
addition to proinflammatory effects, UV-induced neuro-
peptides and neurohormones such as CGRP and a-
melanocyte-stimulating hormone may have immuno-
suppressive effects in the skin. This review will focus on
the role that SP, CGRP, POMC peptides, and their
receptors may play in modulating UV-induced inflam-
mation in the skin. Key words: calcitonin gene-related peptide/
proopiomelanocortin/skin immune system/substance P. Journal
of Investigative Dermatology Symposium Proceedings 4:55–60,
1999
DNA repair, modulated intracellular signal transduction, impaired
antigen-presenting function by Langerhans cells, dendritic cells (DC),
or macrophages, or the induction of anti-inflammatory mediators such
as the interleukin 1 receptor antagonist, IL-10, or α-MSH (Kripke,
1990; Boonstra and Savelkoul, 1997; Garssen et al, 1997; Luger et al,
1997; Norris et al, 1997)
Afferent sensory nerves in the skin are another potential source of
released inflammatory mediators after UV exposure. Unmyelinated
C-fibers and myelinated Aδ-fibers that are derived from dorsal root
ganglions innervate the epidermis and the dermis and are capable of
releasing a variety of neuropeptides upon noxious stimuli such as
chemical, electrical, thermal, mechanical injury, and UV irradiation.
Immunoreactivity for the tachykinins SP and neurokinin A (NKA),
CGRP, vasoactive intestinal peptide, peptide histidine-isoleucinamide,
neuropeptide Y, galanin, somatostatin, atrial natriuretic peptide and
proopiomelanocortin (POMC) peptides such as α- and γ-melanocyte-
stimulating hormone (MSH), adrenocorticotropic hormone (ACTH),
β-lipotropic hormone, or β-endorphin have been detected in human
skin or skin cells (reviewed in Scholzen et al, 1998a; Luger et al, 1997).
Released neuropeptides in the skin not only function as neuro-
transmitters for pain and itch but also may act as mediators of immunity
and inflammation. The inflammatory changes that are mediated by
sensory nerves via the secretion of neuropeptides in a variety of tissues,
including skin, are often referred to as neurogenic inflammation.
Originally, the term neurogenic inflammation was used to describe a
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vascular response consisting of plasma extravasation and vasodilatation
that occured after electrical or chemical stimulation of sensory nerves.
The tachykinins SP and NKA are primarily responsible for plasma
extravasation, whereas CGRP and SP mediate vasodilatation (Delay-
Goyet et al, 1992; Quartara and Maggi, 1998). According to the axon-
reflex model of neurogenic inflammation, injury to tissues innervated
by sensory nerves triggers an immediate signal to the dorsal root
ganglion and the central nervous system (orthodromic response), which
transmits the sensation of pain. A signal in the reverse direction
(antidromic response) leads to the immediate release of neuropeptides
in peripheral innervated tissues (Szolcsanyi, 1996). Receptors for
neuropeptides released from these sensory nerves are found on a variety
of nonimmune and immune cells. A broad range of target cell responses
to SP, CGRP, and other neuropeptides have been described. The term
neurogenic inflammation can be associated with diverse neuropeptide-
induced activities such as mast cell degranulation, epithelial cell mediator
secretion, and leukocyte activation, recruitment, vascular adhesion,
and transmigration (Holzer, 1988; Ansel et al, 1996; Baluk, 1997;
Scholzen et al, 1998a). The role of neuropeptides and neuroendocrine
hormones in modulating the skin immune system following cutaneous
UV irradiation will be the focus of this paper.
NEUROPEPTIDES
UV effects on the cutaneous sensory nervous system Previous
evidence for the participation of sensory nerves in UV-induced
inflammation was derived from studies in rabbits demonstrating
increased activity of nociceptive sensory nerves in the rabbit ear
following UV irradiation that also increased the sensitivity of these
nerves to other stimuli such as heat or bradykinin injection (Szolcsanyi,
1987). Electrophysiological and immunohistochemical studies have
demonstrated that UV exposure of rat hindpaw skin resulted in
spontaneous, long-lasting firing of sensory A- and C-fibers innervating
the irradiated area and the development of prolonged behavioral
hyperalgesia in response to thermal or mechanical stimuli (Thompson
et al, 1994; Eschenfelder et al, 1995; Polgar et al, 1998). In addition,
increased skin blood flow (erythema) was detected in the irradiated rat
hindpaws and rat ears exposed to UV that was associated with a long-
lasting increase in ear thickness (Eschenfelder et al, 1995). The observed
UV-induced tissue reactions such as erythema and plasma extravasation
were very similar to those demonstrated for antidromic nerve stimula-
tion (Szolcsanyi, 1996). Among the neuropeptides released from sensory
nerves in the skin, SP and CGRP appeared to be important mediators
for UV-induced neuroinflammation of the skin. Immunohistochemical
analysis of rat hindpaw skin after UV irradiation revealed a significant
increase in SP and CGRP immunoreactivity and sensory nerve fibers
24 h post-irradiation (Eschenfelder et al, 1995).
The tachykinin SP belongs to a group of neuropeptides that includes
SP, NKA, and neurokinin K, as well as the NKA-variants neuropeptide
K and neuropeptide Y. In the skin, SP is released from sensory nerves
that are in contact with microvascular endothelial cells, mast cells, hair
follicles, and epidermal cells. The cellular effects of SP are mediated
by the activation of a group of 7-transmembrane G-protein-coupled
neurokinin receptors (NK-1R, NK-2R, and NK-3R). SP exhibits
high-affinity binding for NK-1R, which is expressed on a variety of
skin cells including keratinocytes, Langerhans cells, endothelial cells,
and mast cells (Regoli et al, 1996; Scholzen et al, 1998a)
CGRP is a 37 amino acid peptide that is generated from the same
gene locus as the calcium-regulating hormone calcitonin by tissue-
specific, differential RNA splicing. CGRP is one of the most abundant
neuropeptides in the skin and has been detected in C-fibers of sensory
nerves associated with blood vessels as well as in free nerve endings in
the skin contacting dermal mast cells, Merkel cells, melanocytes,
keratinocytes, and Langerhans cells. CGRP activates two CGRP
receptors subtypes (CGRP-1R and 2R), which also belong to the
superfamily of G-protein coupled receptors and can be distinguished
by their sensitivity to the peptide antagonist CGRP8–37. CGRP-1R
was defined as being sensitive to this antagonist, whereas CGRP-2R
was less sensitive (Emeson 1996; Hall and Brain, 1996; Scholzen
et al, 1998a).
The release of SP and CGRP in the skin after UV irradiation is of
particular interest because SP and CGRP alter a number of biologic
functions of skin cells during cutaneous neuroinflammation, including
cytokine and chemokine production, cell proliferation, cellular adhesion
molecule expression, and immunocompetent and antigen-presenting
cell (APC) functions (Ansel et al, 1996; Lambert and Granstein, 1998;
Scholzen et al, 1998a). For example, SP stimulates the expression of
vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion
molecule-1 (ICAM-1) in the skin and both SP and CGRP enhance
the functional adhesion of particular leukocytic cell lines to human
dermal microvascular endothelial cells (HDMEC) in vitro (Quinlan
et al, 1998, 1999).1 Thus, because they are coreleased from sensory
nerves in the skin, SP and CGRP may act synergistically in modulating
cutaneous inflammatory responses in epidermal and dermal cells after
UV exposure.
Neuropeptide participation in UV-induced cutaneous edema
and erythema There is considerable experimental data to suggest
that neuropeptides may play an important role in the edema and
erythema that develop following UV irradiation of the skin by their
direct ability to influence vasodilation and microvascular permeability
of blood vessels in the skin and by their ability to influence mast cell
function. One of the most prominent effects of CGRP in vivo appears
to be its vasodilatory action and its capability to potentiate microvascular
permeability and edema formation caused by other neuropeptides.
Intradermal injection of CGRP caused long-lasting erythema even in
femtomolar to picomolar doses (Brain, 1996). SP is well known to
provoke erythema and edema via a mast cell-dependent and a mast
cell-independent pathway. Interestingly, in vitro studies using rat periton-
eal mast cells demonstrated that UV does not have a direct impact on
histamine release from these cells. Moreover, these studies indicate that
SP-induced release of histamine, which is known to cause vasodilatation
via activation of H1 receptors on vascular smooth muscle cells, could
be inhibited in a dose-dependent manner by pretreatment of mast cells
with UV (Amano et al, 1997). These data, however, are not necessarily
in conflict with the observation that UV exposure results in vasodilat-
ation and plasma extravasation. Because elevated histamine levels were
detected up to 8 h after UV (Gilchrest et al, 1981), the mast
cell-dependent vasodilatation and plasma extravasation involving SP-
induced mast cell histamine release may only be of importance for an
immediate increase in microcirculation and plasma extravasation after
UV (Columbo et al, 1996). In another study, the presence of nerves
with histamine immunoreactivity has been demonstrated in rat skin,
suggesting the existence of a mast cell-independent mechanism for
vasodilatation via nerve-derived histamine (Johansson et al, 1995).
Recently, it has also been demonstrated that intradermal injection of
the SP antagonist spantide as well as the epicutaneous application of
the NK-1R antagonist CP-96 345 significantly reduced the UV-
induced ear swelling response as well as the skin blood flow in rat
(Benrath et al, 1995a; Benrath et al., 1995b). Injection of the CGRP
antagonist CGRP(8–37) attenuated skin blood flow, but did not prevent
the development of edema after UV. Because increased nitric oxide
(NO) synthase activity in nerve fibers in the UV-exposed area of rat
skin has been detected (Benrath et al, 1995a), these and other studies
(Goldsmith et al, 1996; Kakuyama et al, 1998) also suggest that UV-
induced NO release from sensory nerves may participate in the vascular
component of UV-induced neuroinflammation. In addition to its direct
vasodilatory action it has been proposed that NO may be necessary
for either the release of CGRP from sensory nerves or its subsequent
activity (Holzer et al, 1995). Thus, UV-induced CGRP, SP, and NO
may contribute to the prolonged edema and erythema that develop
after UV irradiation (Bowden et al, 1996).
The role of cutaneous neuropeptides in UV-induced edema is
also supported by recent studies in our laboratory using genetically
engineered mice deficient for neutral endopeptidase (NEP), the
1Scholzen TE, Burbach G, Song IS, et al: CGRP induction of human dermal
microvascular endothelial cell (HDMEC) chemokine expression and functional
adhesionof leukocytes toHDMEC in vitro.ArchDermatolRes291:116, 1999 (abstr.)
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Figure 1. Photodermatitis in NEP(–/–) and NEP(1/1) mice. NEP(–/–)
or NEP(1/1) mice were exposed to a single whole body dose of 1.2 J UVB light
(Westinghouse FS/20 bulbs) per m2. The ear swelling response was determined
over time from 16 to 144 h post-irradiation. All values are given in µm as
mean 6 SEM, n 5 5. *p , 0.05, ***p , 0.001 for NEP(–/–) mice versus
NEP(1/1) mice.
principal SP-degrading peptidase. NEP(– /–) mice, in contrast to wild-
type NEP(1/1) animals, demonstrated a significantly increased ear
swelling after UVB irradiation (Fig 1) that was histologically accompan-
ied by an increased cutaneous inflammatory infiltrate. These studies
support the concept that the final biologic response of a given
neuropeptide requires not only the presence of the neuropeptide and
its corresponding receptor on the target cells in the skin, but also the
presence of neuropeptide-degrading enzymes such as NEP.
Neuropeptide modulation of pain sensation after UV
exposure There is evidence that UV irradiation of the skin may also
lead to alterations in neuropeptide levels in the peripheral nervous
system that contribute to altered pain sensation. A- and C-fibers
prepared from rat spinal cords after induction of peripheral injury by
UV irradiation demonstrated increased evoked responses that coincided
with hyperalgesia. The increased excitability of nerve fibers could be
blocked by NK-1R and NK-2R antagonists (Thompson et al, 1994;
Eschenfelder et al, 1995). In addition, repeated exposure of rat hindpaw
to UV induced a complex pattern of changes in the spinal SP
immunoreactivity, suggesting that an increased SP production in DRG
neurons was not restricted to the segments that innervate the inflamed
area (Polgar et al, 1998). Analysis of neural CGRP expression paralleled
the SP findings by also demonstrating a long-term increase of CGRP
levels in the rat spinal horn following UV exposure (Gillardon et al,
1992). These studies imply that noxious noninvasive stimuli such as
UV are capable of altering the synaptic transmission and central pain
sensation by modulating the neuropeptide content of sensory nerves.
The latter may be responsible for the development of inflammatory
tissue hyperalgesia during UV-induced inflammation.
The effect of neuropeptides and neurotrophins on repair of
cutaneous UV injury An increasing number of studies have shown
that sensory innervation affects tissue repair and wound healing (Ansel
et al, 1996). For example, the surgical resection of cutaneous nerves as
well as certain sensory defects leads to impaired wound healing or the
development of nonhealing ulcers (Ansel et al, 1996). On a cellular
level, SP, CGRP, and NKA have been reported to enhance the
proliferation of keratinocytes, melanocytes, fibroblasts, and endothelial
cells in vitro, to induce neovascularization in vivo, and to promote the
release of growth factors (Ansel et al, 1996). In addition, topical
application of the NK-1R antagonist CP-96 345 significantly delayed
wound healing in UV-injured rat skin (Benrath et al, 1995b). It
has also been reported that UV irradiation can induce epidermal
neurotrophins such as nerve growth factor (NGF) (Gillardon et al,
1995; Gilchrest et al, 1996; Bayerl et al, 1997) that are known to
promote nerve regeneration and reinnervation of the skin, and to
protect epidermal cells from UV-induced apoptotic cell death (Ansel
et al, 1996; Tron et al, 1990; Zhai et al, 1996). The release of NGF
after UV may be secondary to UV-induced neuropeptides because
both NKA and SP are capable of inducing NGF expression in
keratinocytes.2 Thus, these findings indicate that endogenous neuropep-
tides may have a trophic function in tissue damage after UV exposure.
Neuropeptide participation in UV-induced immuno-
suppression In addition to proinflammatory effects, UV exposure
of the skin results in a variety of immunosuppressive effects such as
impaired CHS or DTH reactions and the induction of tolerance. These
effects have been linked to alterations in epidermal and dermal APC
including Langerhans cells, dermal DC, and macrophages that may be
mediated directly or indirectly by UV-released soluble factors like
IL-10, TNFα, or urocanic acid (Kondo et al, 1994; Kurimoto and
Streilein, 1992; Beissert et al, 1996). The role of neuropeptides in UV-
induced immunosuppression is supported by a number of recent
investigations. Several studies have linked the UV-induced suppression
of DTH and CHS reactions to released CGRP and the neuroendocrine
hormone α-MSH. CGRP is released from peripheral sensory nerves
after UV exposure from neurons that are in intimate contact with
epidermal Langerhans cells and mast cells. CGRP has been found to
reduce Langerhans cells density and locally impair Langerhans cell and
dermal DC functions (Yoshikawa and Streilein, 1990; Niizeki et al,
1997). Additional evidence for the role of CGRP in mediating UV-
induced CHS and DTH suppression is derived from studies using
cultured Langerhans cell and Langerhans cell lines. It was found
that CGRP inhibited both proliferation and antigen presentation by
peripheral blood mononuclear cells and Langerhans cells (Fox et al,
1997). This may be due in part to upregulation of anti-inflammatory
cytokines such as IL-10 that are capable of suppressing T cell functions.
Additionally, downregulation of pro-inflammatory cytokines (IL-1 and
IL-12) by CGRP as well as suppression of the costimulatory molecule
CD86, but not CD80, on Langerhans cells or macrophages may inhibit
T cell activation (Torii et al, 1997; Lambert et al, 1998).
In summary, these in vitro and in vivo observations support the
possibility that SP and CGRP can directly or indirectly modulate UV-
induced cutaneous inflammation by the (i) induction of vasodilatation
and plasma extravasation; (ii) modulation of UV-induced cytokine and
chemokine release; (iii) regulation of microvascular endothelial cellular
adhesion molecule expression; and (iv) mediation of pain sensation
following UV irradiation. CGRP also appears to have immunosuppres-
sive properties primarily by impairing antigen-processing and pre-
sentation.
NEUROENDOCRINE HORMONES
The effect of UV irradiation on proopiomelanocortin peptides
and melanocortin receptors in the skin It has been established
that the skin is a source and target of neuroendocrine hormones of the
proopiomelanocortin (POMC) family, including α-, β-, γ-MSH,
ACTH, β-LPH, or β-END. Expression and release of these peptides has
been detected in normal murine or human keratinocytes, melanocytes,
Langerhans cells, and fibroblasts as well as by transformed keratinocyte
and melanocyte cell lines in vitro. Most of these peptides have also
been identified by immunohistochemical staining in both murine and
human skin in vivo.
POMC peptides exert their effects by activating specific melanocortin
receptors (MC-1R–5R) that belong to the G-protein-coupled receptor
superfamily. The most abundant MC-R in the skin is MC-1R, which
exhibits high affinity for α-MSH and ACTH (Table I). Recent studies
with both keratinocytes and dermal microvascular endothelial cells
indicate that prominent regulators of MC-1R expression in the skin
are IL-1β and α-MSH (Cone et al, 1996; Luger et al, 1997). There is
increasing evidence that UV irradiation may play an important role in
regulating the production and the post-translational processing of
POMC as well as MC-1R expression. POMC mRNA and peptides
including α-MSH, ACTH, β-LPH, and β-END can be upregulated
by UV or IL-1 in human melanocytes, melanoma cells, keratinocytes,
2Burbach GJ, Kim KH, Song IS, et al: Cutaneous neuropeptide induction of
keratinocyte nerve growth factor. J Invest Dermatol 112:533, 112, 1999 (abstr.)
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Table I. Expression of MC-R and their specific ligands
Receptor Tissue/cellular source Specific ligand
MC-1R melanocytes α-MSH, ACTH
monocytes
macrophages
mast cells
keratinocytes
fibroblasts
MC-2R adrenal tissues, brain adipocytes ACTH, α-, β-, γ-MSH
MC-3R brain, placenta, gut heptapeptide core of ACTH,
α-, β-, γ-MSH
MC-4R brain ACTH, α-, β-, γ-MSH,
β-LPH
MC-5R skeletal muscle, brain, spleen, ACTH, α-, β-, γ-MSH
thymus, adipocytes
HDMEC, and some epidermoid carcinoma cell lines (Schauer et al,
1994; Chakraborty et al, 1995, 1996; Wintzen and Gilchrest, 1996).
Numerous studies indicate that in the pituitary POMC expression
and post-translational POMC prohormone processing occurs in a cell-
and tissue-specific manner involving prohormone convertases (PC-)
1 and 2. The expression of these PC seemed to be restricted to cells
of endocrine and neuroendocrine origin (Castro and Morrison, 1997)
and relatively little is known about the post-translational processing of
the inactive POMC prohormone in nonpituitary tissues, including
skin. Reverse transcriptase–polymerase chain reaction studies indicate
that keratinocytes, certain epidermoid cell lines, and HDMEC
express PC-1 mRNA (Brzoska et al, 1997). UV light, IL-1, and α-
MSH itself are capable of regulating the mRNA expression of PC.
Although β-endorphin and α-MSH can be detected in keratinocytes
and α-MSH can be detected in HDMEC, only the mRNA for the
PC-2-activating protein 7B2 could be detected in these cells (Scholzen
et al, 1999). Whereas PC-2 expression is required for processing
POMC in pituitary cells, an alternative proteolytic pathway for
POMC processing in skin cells may exist that could involve neutral
endopeptidase (NEP) or a peptidase that has not yet been identified
(Castro et al, 1989; Smith et al, 1992).
UV light can also induce the production of cytokines such as IL-1 and
IL-6 in skin cells (Luger and Schwarz, 1995; as well as simultaneously
upregulating the expression of both POMC and PC-1 in these skin
cells. Because MC-1R expression is upregulated by IL-1 and/or UV-
light in melanocytes, keratinocytes, and HDMEC (Brzoska et al, 1997;
Hartmeyer et al, 1997), these same mediators may increase the sensitivity
of certain cutaneous or noncutaneous target cells for POMC peptides
by upregulating MC-1R expression (Brzoska et al, 1997). Another
potential mechanism for cutaneous POMC induction is derived from
studies demonstrating that murine and human skin express mRNA for
corticotrophin releasing hormone (CRH) and CRH receptors. CRH
receptors are upregulated in human keratinocytes and melanocytes
following UVB irradiation (Slominski et al, 1995, 1996). Hypothalamus-
derived CRH, like IL-1 or IL-6, is an important stimulus for POMC
expression in the pituitary or in pituitary cells in vitro. Consequently,
it has been proposed that an equivalent of the hypothalamic-pituitary-
adrenal (HPA) axis exists in the skin. The conservation of this important
link between the HPA axis as central regulatory unit for a coordinated
response to exogenous stress and the immune system may be of
importance for the cutaneous response to injury after exposure to
external agents such as UV irradiation. These findings have a number
of implications regarding potential mechanisms that could be involved
in protection of the skin from UV, the repair of photodamaged skin,
alterations of biologic functions of epidermal and dermal cells, and
local or systemic immunomodulation via POMC peptides, in particular
by α-MSH.
a-MSH protection in response to cutaneous UV exposure
Various in vivo and in vitro studies demonstrate the participation of
α-MSH and MC-R in UV-induced melanogenesis. Melanogenesis
represents one of the most important protection mechanisms against
harmful effects of UV and includes the increase in melanocyte density,
melanin biosynthesis, and transfer of pigment granules to surrounding
keratinocytes. These studies demonstrated that melanocytes can
specifically respond to ACTH and α- and β-MSH. UV-induced
POMC peptides could either activate melanocyte melanogenesis via
MC-R activation or ‘‘prime’’ these cells for UV-induced melanogenesis.
MSH-induced cAMP formation in melanocytes appears to be an
obligatory step for melanogenic responses to UVB (Pawelek et al,
1992; Suzuki et al, 1996; Im et al, 1998).
Potential immunomodulatory effects of POMC peptides in
photodermatitis Among POMC-peptides, α-MSH is regarded as
the neurohormone with a broad range of immunomodulatory capacit-
ies. α-MSH can act centrally within the brain to inhibit local
inflammation and peripheral inflammation. This neurohormone can
also act locally in the skin by inhibiting the production and function
of certain pro-inflammatory cytokines, upregulating anti-inflammatory
mediators, and inhibiting inflammatory actions of cutaneous immuno-
competent cells (Luger et al, 1998; Lipton and Catania, 1998). In the
skin, POMC peptides are capable of modulating cytokine, chemokine,
and adhesion molecule expression in keratinocytes, melanocytes,
fibroblasts,3 and HDMEC4 (Hartmeyer et al, 1997; Luger et al, 1998;
Morandini et al, 1998). Recent studies also revealed that α-MSH can
downregulate the LPS or TNFα-induced expression of E-selectin and
VCAM-1 as well as the functional adhesion of T- or B-lymphoblastoid
cell lines to HDMEC in vitro. Interestingly, α-MSH alone had a
dose-dependent stimulatory effect on the lymphocyte–endothelial cell
interaction (Scholzen et al, unpublished observations). Thus, it can be
speculated that the stimulatory effect of α-MSH on leukocyte recruit-
ment may assist in the initiation of inflammatory responses to UV. In
contrast, α-MSH could also inhibit the recruitment of inflammatory
cells by activated endothelium during the late phase of photodermatitis
and thus suppress cutaneous inflammation. Recent studies also indicated
that some of these α-MSH anti-inflammatory properties may be
mediated via downregulation of cellular NF-κB activity5,6 (Manna and
Aggarwal, 1998).
POMC peptides and UV-induced immunosuppression In vivo
α-MSH can impair CHS and DTH reactions by inhibiting both the
sensitization and the elicitation phases of these responses and by
inducing hapten-specific tolerance in mice (Grabbe et al, 1996). UV-
induced IL-10 can have similar immunosuppressive effects as α-MSH
(Enk et al, 1995). Because α-MSH stimulation can increase the in vitro
IL-10 production in human monocytes (Bhardwaj et al, 1996, 1997),
it may be that IL-10 induction by α-MSH mediates some of the
immunosuppressive effects of UV. In addition, α-MSH can inhibit
IFNγ production in T lymphocytes and downregulate the
costimulatory molecule CD86, but not CD80, on monocytes and
peripheral blood-derived DC (Bhardwaj et al, 1997).7 In this respect,
the activity of α-MSH strongly resembles that of CGRP and thus may
contribute to the UV-mediated downregulation of pro-inflammatory
molecules, induction of immunosuppressive cytokines, and inhibition
of APC activation.
CONCLUSION
UV irradiation can modulate the production of cutaneous cytokines,
chemokines, neuropeptides, neuropeptide-degrading enzymes, neuro-
3SchulteU,BecherE,KaldenD-H, et al: Evidence for a functionalmelanocortin
receptor on human fibroblasts. J Invest Dermatol 110:479, 1998 (abstr.)
4Scholzen T, Kalden D-H, Luger T A, Armstrong C A. Ansel JC: α-
melanocyte-stimulating hormone (α-MSH) modulates TNFα or IL-1β-induced
production of interleukin-8 and GROα by human dermal microvascular
endothelial cells. Arch Dermatol Res 290:104, 1998 (abstr.)
5Brzoska T, Kalden D-H, Scholzen T, et al: α-melanocyte stimulating hormone
downregulates IL-1 mediated target gene expression by attenuation of NF-κB
activation. J Invest Dermatol 110:495, 1998 (abstr.)
6Kalden D-H, Fastrich M, Brzoska T, et al: Alpha-melanocyte-stimulating
hormone reduces endotoxin-induced activation of nuclear factor-κB in
endothelial cells. J Invest Dermatol 110:495, 1998 (abstr.)
7Becher E, Mahnke K, Brzoska T, Schwarz T. Luger TA: Human monocyte-
derived dendritic cells express a functional α-MSH receptor – downregulation of
accessory molecule expression by α-MSH. Arch Dermatol Res 290:88, 1998 (abstr.)
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Figure 2. Immunostimulatory and immunosuppressive effects in the skin
mediated by UV light.
trophins, and other inflammatory mediators that link the cutaneous
immune, the sensory nervous, and the neuroendocrine system. By
inducing cytokines, cutaneous neuropeptides, and neuroendocrine
hormones such as SP, CGRP, and α-MSH, UV irradiation can initiate
or amplify the inflammatory response in acute photodermatitis. Some
of these mediators also suppress the cutaneous inflammatory response
to UV irradiation (Fig 2). To date it is not clear how and where pro-
and anti-inflammatory signals derived from sensory neurons and
skin cells after UV exposure are integrated to result in a final
biologic response.
Thus, on the one hand UV exposure leads to the release of pro-
inflammatory factors and on the other hand UV also induces the
production of mediators such as α-MSH and CGRP, which have
immunosuppressive effects. As in all inflammatory responses there is a
complex interaction and interdependent biologic response to UV with
both proinflammatory and anti-inflammatory agents coreleased in the
affected tissue. The relative balance and activities of these factors will
determine the clinical outcome of the host response. Inflammation
serves as a critical early, rapid innate host immune response to a variety
of microbial and nonmicrobial agents. In highly evolved hosts such as
man, the inflammatory response seeks to neutralize and isolate these
foreign agents, while the cognate immune system is activated and
mobilized. All goes well with this scenario unless the offending agents
cannot be eliminated and/or if the inflammatory process continues
unabated. To prevent the latter, a variety of mechanisms have evolved
that check the persistent inflammatory process. These include the rapid
desensitization of target cells responding to the inflammatory mediators,
the presence of numerous proteolytic enzymes to degrade peptide
mediators, and the release of anti-inflammatory factors such as IL-10,
TGF-β, α-MSH, and in some cases CGRP. These anti-inflammatory
agents are often released in response to specific inflammatory molecules.
Therefore, they do not prevent the initial important host inflammatory
response, but rather they serve to dampen this response and prevent it
from continuing for a prolonged period of time, which would have
detrimental consequences for the host. Thus, it appears that UV
neuroinflammation follows the same general paradigm as other types
of inflammation. Progress in understanding how neuropeptides and
neuroendocrine hormones participate and interact on a molecular and
cellular basis in the UV modulation of the skin immune system is
essential to improved understanding of both the beneficial effects of
UV in clinical treatment of certain skin diseases such as psoriasis, and
the mechanisms of skin carcinogenesis after UV exposure.
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